Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, United States
Medical clinic in Jacksonville, Florida
5200 Belfort Rd #420, Jacksonville, FL 32256
About Clinical Neuroscience Solutions, Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Clinical Neuroscience Solutions, Inc.
During the past decade, Clinical Neuroscience Solutions, Inc. conducted 103 clinical trials. In the 10-year time frame, 103 clinical trials started and 84 clinical trials were completed, i.e. on
average, 81.6% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 45 clinical trials were completed. i.e. 155.2%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
2006-12-01
Active, not recruiting
348
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
2004-08-15
Active, not recruiting
406
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)
2003-12-01
2004-10-01
Completed
206
Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
2004-08-18
Completed
144
Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
2005-03-21
2022-02-22
Active, not recruiting
1,157
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
2004-12-15
Active, not recruiting
460
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Clinical Neuroscience Solutions, Inc." #1 sponsor was "Pfizer" with 23 trials, followed by "Shire" with 21 trials
sponsored, "Sunovion" with 14 trials sponsored, "Eli Lilly and Company" with 10 trials sponsored and "Allergan"
with 10 trials sponsored. Other sponsors include 91 different institutions and
companies that sponsored additional 58 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Neuroscience Solutions, Inc."
#1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Premier Research Group plc" with 2 trials as a collaborator and "Purdue Pharma LP" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at Clinical Neuroscience Solutions, Inc.
According to Clinical.Site data, the most researched conditions in "Clinical Neuroscience Solutions, Inc." are
"Major Depressive Disorder" (24 trials), "ADHD" (11 trials), "Depressive Disorder, Major" (9 trials), "Migraine" (9 trials) and "Attention Deficit Hyperactivity Disorder (ADHD)" (7 trials). Many other conditions were trialed in "Clinical Neuroscience Solutions, Inc." in a lesser frequency.
Clinical Trials Intervention Types at Clinical Neuroscience Solutions, Inc.
Most popular intervention types in "Clinical Neuroscience Solutions, Inc." are "Drug" (165 trials), "Other" (11 trials), "Biological" (8 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (102 trials), "Dasotraline" (6 trials), "placebo" (5 trials), "Atogepant" (4 trials) and "Galcanezumab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Clinical Neuroscience Solutions, Inc.
The vast majority of trials in "Clinical Neuroscience Solutions, Inc." are
167 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Clinical Neuroscience Solutions, Inc.
Currently, there are NaN active trials in "Clinical Neuroscience Solutions, Inc.".
undefined are not yet recruiting,
16 are recruiting,
5 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 130 completed trials in Clinical Neuroscience Solutions, Inc.,
undefined suspended trials,
and 19 terminated clinical trials to date.
Out of the total trials that were conducted in Clinical Neuroscience Solutions, Inc., 1 "Phase 1"
clinical trials were conducted, 62 "Phase 2" clinical
trials and 108 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 13 trials, and there were
also 1 trials that are defined as “Not Applicable".